Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Meda was a leading international specialty pharmaceutical company with a broad commercial portfolio in allergy/respiratory care, CNS disorders, women’s health/gastroenterology/pain management. Its marketed products included prescription drugs such as Astelin nasal spray for allergies and Onsolis for cancer pain. The company expanded through acquisitions of brands/products/divisions in Europe and the US. It was acquired by Mylan in a €7.2 billion deal in August/September of 2016.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Meda.